NanoBio(R) Corporation Initiates Phase 2b Clinical Trial For Herpes Labialis Treatment

Fri, 16 Feb 2007 02:00 PM EST

... NanoBio(R) Corporation, a biopharmaceutical company developing novel products for the treatment and prevention of topical infections, today announced that it has begun enrolling patients in its Phase 2b study of NB-001, a drug candidate for the topical treatment of Herpes labialis. [click link for full article] ...